NCT04550416View on ClinicalTrials.gov

Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study

NACompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Prostate Cancer
Interventions
OTHER

ProMark Information and Test Results

Participants in the intervention arm will receive information (both print and webinar format) about ProMark in between Round 1 and Round 2 data collection, as well as appropriate ProMark test results for each of the vignette-based simulated patients that they care for in the second round of data collection.

Trial Locations (1)

94901

QURE Healthcare, San Rafael

All Listed Sponsors
lead

Qure Healthcare, LLC

INDUSTRY

NCT04550416 - Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study | Biotech Hunter | Biotech Hunter